Gregory T. MacLennan

16.7k total citations
321 papers, 11.4k citations indexed

About

Gregory T. MacLennan is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Gregory T. MacLennan has authored 321 papers receiving a total of 11.4k indexed citations (citations by other indexed papers that have themselves been cited), including 144 papers in Pulmonary and Respiratory Medicine, 141 papers in Surgery and 111 papers in Molecular Biology. Recurrent topics in Gregory T. MacLennan's work include Bladder and Urothelial Cancer Treatments (64 papers), Urinary and Genital Oncology Studies (61 papers) and Urologic and reproductive health conditions (50 papers). Gregory T. MacLennan is often cited by papers focused on Bladder and Urothelial Cancer Treatments (64 papers), Urinary and Genital Oncology Studies (61 papers) and Urologic and reproductive health conditions (50 papers). Gregory T. MacLennan collaborates with scholars based in United States, Italy and Spain. Gregory T. MacLennan's co-authors include Liang Cheng, Antonio López-Beltrán, Rodolfo Montironi, Sanjay Gupta, Pingfu Fu, John N. Eble, Martin I. Resnick, Sanjeev Shukla, Shaobo Zhang and Ming‐Sheng Wang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Gregory T. MacLennan

319 papers receiving 11.1k citations

Peers

Countries citing papers authored by Gregory T. MacLennan

Since Specialization

Citations

This map shows the geographic impact of Gregory T. MacLennan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory T. MacLennan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory T. MacLennan more than expected).

Fields of papers citing papers by Gregory T. MacLennan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory T. MacLennan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory T. MacLennan. The network helps show where Gregory T. MacLennan may publish in the future.

Co-authorship network of co-authors of Gregory T. MacLennan

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory T. MacLennan. A scholar is included among the top collaborators of Gregory T. MacLennan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory T. MacLennan. Gregory T. MacLennan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clear Cell Renal Cell Carcinoma: A Comprehensive Review of its Histopathology, Genetics, and Differential Diagnosis 2024 ·International Journal of Surgical Pathology ·Behtash Ghazi Nezami, Gregory T. MacLennan	6
2	Dosimetric and On-treatment Clinical Results of a Volumetric-based Skin-sparing Planning Technique for Patients Treated to the Breast and Chest Wall With Pencil-Beam Scanning Proton Therapy 2024 ·Advances in Radiation Oncology ·Avani D. Rao, (unknown), (unknown), (unknown), Gregory T. MacLennan, (unknown), (unknown), (unknown), (unknown), Hongkun Wang, Stella Hetelekidis, Song Gao, (unknown), Ashish Chawla, (unknown), (unknown), (unknown)	1
3	Frequent Telomerase Reverse Transcriptase Promoter and Fibroblast Growth Factor Receptor 3 Mutations Support the Precursor Nature of Papillary Urothelial Hyperplasia of the Urinary Bladder 2023 ·Modern Pathology ·Liang Cheng, Antonio López-Beltrán, Ming‐Sheng Wang, Rumeal D. Whaley, (unknown), (unknown), (unknown), Alessia Cimadamore, (unknown), (unknown), Gregory T. MacLennan, Adeboye O. Osunkoya, Rodolfo Montironi, Shaobo Zhang	2
4	Multi‐scale statistical deformation based co‐registration of prostate MRI and post‐surgical whole mount histopathology 2023 ·Medical Physics ·Lin Li, Rakesh Shiradkar, (unknown), (unknown), (unknown), Vidya Sankar Viswanathan, Gregory T. MacLennan, (unknown), Karishma Gupta, (unknown), Sree Harsha Tirumani, Cristina Magi‐Galluzzi, Andrei S. Purysko, Anant Madabhushi	1
5	Identification of Key Genes Associated with Progression and Prognosis of Bladder Cancer through Integrated Bioinformatics Analysis 2021 ·Cancers ·Shiv Verma, Eswar Shankar, Spencer Lin, Vaibhav Singh, E. Ricky Chan, Shufen Cao, Pingfu Fu, Gregory T. MacLennan, Lee Ponsky, Sanjay Gupta	10
6	Focal Prostate Stereotactic Body Radiation Therapy With Correlative Pathological and Radiographic-Based Treatment Planning 2021 ·Frontiers in Oncology ·(unknown), Bryan Traughber, Michael Kharouta, Tarun K. Podder, Simon S. Lo, Lee Ponsky, Gregory T. MacLennan, Raj Mohan Paspulati, (unknown), Mitchell Machtay, Rodney J. Ellis	3
7	Androgen Deprivation Induces Transcriptional Reprogramming in Prostate Cancer Cells to Develop Stem Cell-Like Characteristics 2020 ·International Journal of Molecular Sciences ·Shiv Verma, Eswar Shankar, (unknown), (unknown), (unknown), Vaibhav Singh, E. Ricky Chan, Gregory T. MacLennan, Sanjay Gupta	34
8	Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine 2018 ·PMC ·Liang Cheng, Antonio López-Beltrán, Francesco Massari, Gregory T. MacLennan, Rodolfo Montironi	0
9	Small-cell Carcinomas of the Urinary Bladder and Prostate: TERT Promoter Mutation Status Differentiates Sites of Malignancy and Provides Evidence of Common Clonality Between Small-cell Carcinoma of the Urinary Bladder and Urothelial Carcinoma 2017 ·European Urology Focus ·David S. Priemer, Ming‐Sheng Wang, Shaobo Zhang, Antonio López-Beltrán, Erik Kouba, Rodolfo Montironi, Darrell D. Davidson, Gregory T. MacLennan, Lisha Wang, Adeboye O. Osunkoya, Youping Deng, Robert E. Emerson, Liang Cheng	28
10	Fluorescence in situ Hybridization in Surgical Pathology: Principles and Applications 2017 ·IUScholarWorks (Indiana University) ·Liang Cheng, Shaobo Zhang, Lisha Wang, Gregory T. MacLennan, Darrell D. Davidson	5
11	Solitary fibrous tumour of the genitourinary tract: a clinicopathological study of 11 cases and their association with the NAB2 - STAT6 fusion gene 2016 ·Journal of Clinical Pathology ·Erik Kouba, (unknown), Shaoxiong Chen, Sean R. Williamson, David J. Grignon, John N. Eble, Gregory T. MacLennan, Rodolfo Montironi, Antonio López-Beltrán, Adeboye O. Osunkoya, Shaobo Zhang, Ming‐Sheng Wang, Lisha Wang, (unknown), Robert E. Emerson, (unknown), M. Francesca Monn, Konstantinos Linos, Liang Cheng	19
12	Synergistic Simvastatin and Metformin Combination Chemotherapy for Osseous Metastatic Castration-Resistant Prostate Cancer 2014 ·Molecular Cancer Therapeutics ·Melissa A. Babcook, Sanjeev Shukla, Pingfu Fu, Edwin J. Vazquez, Michelle A. Puchowicz, Joseph Molter, (unknown), Gregory T. MacLennan, Chris A. Flask, Daniel J. Lindner, Yvonne Parker, Firouz Daneshgari, Sanjay Gupta	58
13	Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway 2013 ·Carcinogenesis ·(unknown), Natarajan Bhaskaran, Melissa A. Babcook, Pingfu Fu, Gregory T. MacLennan, Sanjay Gupta	160
14	Hinman's atlas of urosurgical anatomy 2012 ·Elsevier eBooks ·Gregory T. MacLennan, Frank Hinman	11
15	The origins of urothelial carcinoma 2010 ·Expert Review of Anticancer Therapy ·Liang Cheng, Darrell D. Davidson, Gregory T. MacLennan, Sean R. Williamson, Shaobo Zhang, Michael O. Koch, Rodolfo Montironi, Antonio López-Beltrán	44
16	Molecular pathogenesis of urothelial carcinoma: the clinical utility of emerging new biomarkers and future molecular classification of bladder cancer. 2009 ·PubMed ·(unknown), Antonio López-Beltrán, Gregory T. MacLennan, (unknown), Rodolfo Montironi, Liang Cheng	13
17	Prostatic leiomyoma with atypia: follow-up study of 10 cases 2008 ·Annals of Diagnostic Pathology ·Deloar Hossain, Isabelle Meiers, Junqi Qian, Gregory T. MacLennan, David G. Bostwick	15
18	Adenoid Cystic/Basal Cell Carcinoma of the Prostate 2008 ·The Journal of Urology ·Shams Halat, Gregory T. MacLennan	17
19	Blockade of β-Catenin Signaling by Plant Flavonoid Apigenin Suppresses Prostate Carcinogenesis in TRAMP Mice 2007 ·Cancer Research ·Sanjeev Shukla, Gregory T. MacLennan, Chris A. Flask, Pingfu Fu, Anil Mishra, Martin I. Resnick, Sanjay Gupta	100
20	Loss of fragile histidine triad expression in colorectal carcinomas and premalignant lesions. 2000 ·PubMed ·Xingpei Hao, Joseph Willis, T G Pretlow, Jun Rao, Gregory T. MacLennan, I C Talbot, Theresa P. Pretlow	87

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact